Pursuing Distribution and Commercialization of Voice AI Patient Monitoring Solution "Heart to Voice"

GeoYoung, a pharmaceutical distribution company, announced on September 1 that it has signed a memorandum of understanding (MOU) with AIDocure, a digital healthcare firm specializing in voice AI, to cooperate on the distribution and commercialization of a voice AI patient monitoring solution.


Vice President Hakkyung Kim of GeoYoung Hospital Sales Division (left) and CEO Kyung-ho Jung of AIDotCure are posing for a commemorative photo after signing a distribution and commercialization business agreement for the voice AI-based solution 'Heart to Voice.' Photo by GeoYoung

Vice President Hakkyung Kim of GeoYoung Hospital Sales Division (left) and CEO Kyung-ho Jung of AIDotCure are posing for a commemorative photo after signing a distribution and commercialization business agreement for the voice AI-based solution 'Heart to Voice.' Photo by GeoYoung

View original image

Under this agreement, both companies will pursue joint commercialization strategies for digital healthcare products and services, including the sales, distribution, and market entry of AIDocure's voice AI-powered solution 'Heart to Voice (H2V).' Areas of collaboration include: (i) sales and distribution of digital healthcare products and services; (ii) securing market entry channels, marketing, and sales efforts; (iii) joint development and advancement of products and services; and (iv) discovering new business models.


H2V is a voice AI-based digital healthcare solution that analyzes short voice samples collected in daily life to monitor the patient’s condition and changes over time.


AIDocure is developing disease-specific voice AI models based on clinical and voice data obtained from medical institutions. Through H2V, the company aims to establish a patient monitoring environment that enables healthcare providers to continuously track patient status even outside medical facilities. GeoYoung plans to support the market entry and commercialization of digital healthcare products by leveraging its existing pharmaceutical distribution network and business capabilities through this collaboration.


Kim Hakkyung, Vice President of the Hospital Sales Division at GeoYoung, stated, "The pharmaceutical distribution industry is evolving beyond product supply to provide new value to healthcare providers and patients through digital technology and data. We will review various possibilities for collaboration starting with this agreement."



Jeong Kyungho, CEO of AIDocure, said, "For digital medical devices to be utilized in clinical settings, the infrastructure for distribution and commercialization is as important as technology and clinical evidence. By collaborating with GeoYoung, we will build a foundation for H2V's market entry and commercialization."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing